CYTOKINE-PRODUCING FUNCTION OF IMMUNOCOMPETENT BLOOD CELLS AND ITS INTERRELATIONS WITH HEPARANASE-1 EXPRESSION IN GASTRIC CARCINOGENESIS

The aim of present study was to investigate relationships between cytokine-producing potential of immunocompetent blood cells (ICC), and expression of heparanase-1 in stomach adenomas and adenocarcinomas. Cytokine-producing potential of ICC, both spontaneous and induced by polyclonal activators, was studied in peripheral blood of thirty-two patients with adenomas and thirty-six patients with gastric adenocarcinoma. Appropriate values were expressed as an influence index of polyclonal activators (IIPA) upon the cytokine production. In subjects with gastric adenomas, the IIPA indexes based on IL-1ra, ТNFα, IL- 18, and IFNγ production proved to exceed similar parameters for the patients with adenocarcinomas. Expression of heparanase-1 in epithelium of adenomas varied from 0.27 to 3.00. Similar values for adenomatous stroma varied between 2.27 and 11.48. Meanwhile, the variation limits for heparanase-1 expression in adenocarcinomas (as percentage of specifically stained area) were quite considerable (1.79 to 14.26), due to inclusion of adenocarcinomas at variable differentiation stages. Indexes of heparanase-1 expression were shown to be in direct correlation with numbers of regional lymph node metastases. Multivariate analysis revealed a canonical correlation between the levels of heparanase-1 expression in adenomatous epithelium, and IIPA effects upon production of IL-2, IL-6 and IL-8, as well as with effects of IIPA upon production of IL-18, IL-18BP, and IL-8. A canonical correlation was also noted between the heparanase-1 expression in stroma of adenomas, and IIPA upon IL-1ra, TNFα, IL-18 production. The data suggest an involvement of molecular and cellular mechanisms, mediated by cytokines and heparanase-1, thus providing a common vector promoting tumor progression.

1. Бабышкина Н.Н., Стахеева М.Н., Слонимская Е.М., Чердынцева Н.В., Гарбуков Е.Ю. Иммунологические параметры и уровень продукции цитокинов у больных с пролиферативными заболеваниями и раком молочной железы // Цитокины и воспаление, 2006. Т. 5, № 1. С. 37-43. [Babyshkina N.N., Stakheyeva M.N., Slonimskaya E.M., Tcherdyntseva N.V., Garbukov E.Yu. Immu-nological parameters and cytokine production level in patients with proliferative diseases and breast cancer. Tsitokiny i vospalenie = Cytokines and Inflammation, 2006, Vol. 5, no. 1, pp. 37-43. (In Russ.)]

2. Кунин И.С., Бобоев М.М., Куценко О.С. Мостович Л.А., Айдагулова С.В., Григорьева Э.В. Молекулярные маркеры метастазирования аденокарциномы предстательной железы // Онкоурология, 2012. № 4. С. 44-48. [Kunin I.S., Boboev M.M., Kutsenko O.S., Mostovich L.A., Aidagulova S.V., Grigorieva E.V. Molecular markers for metastatic prostate adeno-carcinoma. Onkourologiya = Oncourology, 2012, Vol. 8, no. 4, pp. 48-52. (In Russ.)]

3. Соснина А.В., Аутеншлюс А.И., Великая Н.В., Вараксин Н.А., Рукавишников М.Ю., Михайлова Е.С., Морозов Д.В., Фурсов С.А., Агарина Н.В. Цитокинпродуцирующая функция клеток периферической крови у больных колоректальным раком // Медицинская иммунология, 2011. Т. 13, № 2-3. С. 197-204. [Sosnina A.V., Autenshlyus A.I., Velikaya N.V., Varaksin N.A., Rukhavishnikov M.Yu., Mikhailova E.S., Morozov D.V., Fursov S.A., Agarina N.V. Cytokine-producing function of peripheral blood cells in colorectal cancer Patients. Meditsinskaya immunologiya = Medical Immunology (Russia), 2011, Vol. 13, no. 2-3, pp. 197-204. (In Russ.)] http://dx.doi.org/10.15789/1563-0625-2011-2-3-197-204

4. Соснина А.В., Великая Н.В., Вараксин Н.А., Гришаев Н.П., Аутеншлюс А.И. Роль цитокинов в патогенезе злокачественных новообразований. Новосибирск: ЗАО ИПП ОФСЕТ, 2014. 128 с. [Sosnina A.V., Velikaya N.V., Varaksin N. A., Grishaev N.P., Autenshlyus A. I. The role of cytokines in the pathogenesis of malignant neoplasms]. Novosibirsk: ZAO IPP OFFSET, 2014. 128 p.

5. Bernfield M., Gotte M., Park P., Reizes O., Fitzgerald M., Lincecum J., Zako M. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem., 1999, Vol. 68, pp. 729-777.

6. Capila I., Linhardt R. Heparin-protein interactions. Angew. Chem. Int. Ed. Engl., 2002, Vol. 41, pp. 391-412.

7. Chen G., Wang D., Vikramadithyan R., Yagyu H., Saxena U., Pillarisetti S., Goldberg I. Inflammatory

8. cytokines and fatty acids regulate endothelial cell heparanase expression. Biochemistry, 2004, Vol. 43, no. 17, pp. 4971-4977.

9. Cheng C., Lu X., Wang G. Zheng L., Shu X., Zhu S., Liu K., Wu K., Tong Q. Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features. APMIS, 2010, Vol. 118, no. 11, pp. 855-863.

10. Conti-Freitas L., Foss-Freitas M., Mamede R., Foss N. Effect of BCG stimulus on proinflammatory cytokine production in laryngeal cancer. Cancer Immunol. Immunother., 2009, Vol. 58, no. 1, pp. 25-29.

11. Esko J., Selleck S. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem, 2002, Vol. 71, pp. 435-471.

12. Gomceli I., Demiriz B., Tez M. Gastric carcinogenesis. World J. Gastroenterol., 2012, Vol. 18, no. 37, pp. 5164-5170.

13. Heriot A., Marriott J., Cookson S., Kumar D., Dalgleish A. Reduction in cytokine production in colorectal cancer patients: association with stage and reversal by resection. Br. J. Cancer, 2000, Vol. 82, no. 5, pp. 1009-1012.

14. Lindahl U., Li J. Interactions between heparan sulfate and proteins-design and functional implications. Intl. Rev. Cell Mol. Bio, 2009, Vol. 276, pp. 105-159.

15. Lu B., Finn O. T-cell death and cancer immune tolerance. Cell Death Differ., 2008, Vol. 15, no. 1, pp. 70-79.

16. Neuner A., Schindel M., Wildenbergv U., Muley T., Lahm H., Fische J. Cytokine secretion: clinical relevance of immunosuppression in non-small cell lung cancer. Lung Cancer, 2001, Vol. 34, Suppl. 2, pp. 79-82.

17. Nobuhisa T., Naomoto Y., Ohkawa T., Takaoka M., Ono R., Murata T., Gunduz M., Shirakawa Y., Yamatsuji T., Haisa M., Matsuoka J., Tsujigiwa H., Nagatsuka H., Nakajima M., Tanaka N. Heparanase expression correlates with malignant potential in human colon cancer. J. Cancer Res. Clin. Oncol,, 2005, Vol. 131, pp. 229-237.

18. Ohkawa T., Naomoto Y., Takaoka M., Nobuhisa T., Noma K., Motoki T., Murata T., Uetsuka H., Kobayashi M., Shirakawa Y., Yamatsuji T., Matsubara N., Matsuoka J., Haisa M., Gunduz M., Tsujigiwa H., Nagatsuka H., Hosokawa M., Nakajima M., Tanaka N. Localization of heparanase in esophageal cancer cells: respective roles in prognosis and differentiation. Lab. Invest., 2004, Vol. 84, pp. 1289-1304.

19. Rachel L., Freeman C., Yu D., Hindmarsh E., Tymms K., Parish C. Smith P. Dramatic regulation of heparanase activity and angiogenesis gene expression in synovium from patients with rheumatoid arthritis. Arthritis and Rheumatism, 2008, Vol. 58, no. 6, pp. 1590-1600.

20. Suhovskih A., Tsidulko A., Kutsenko O., Kovner A., Aidagulova S., Ernberg I., Grigorieva E. Transcriptional activity of heparan sulfate biosynthetic machinery is specifically impaired in benign prostate hyperplasia and prostate cancer. Front. Oncol., 2014, Vol. 4., no. 79, pp. 1-10.

21. Takaoka M., Naomoto Y., Ohkawa T., Uetsuka H., Shirakawa Y., Uno F., Fujiwara T., Gunduz M., Nagatsuka H., Nakajima M., Tanaka N., Haisa M. Heparanase expression correlates with invasion and poor prognosis in gastric cancers. Lab. Invest., 2003, Vol. 83, pp. 613-622.

22. Tang W., Nakamura Y., Tsujimoto M., Sato M., Wang X., Kurozumi K., Nakahara M., Nakao K., Nakamura M., Mori I., Kakudo K. Heparanase: a key enzyme in invasion and metastasis of gastric carcinoma. Modern Pathol., 2002, Vol. 15, no. 6, pp. 593-598.

23. Waugh D.J., Wilson C. The interleukin-8 pathway in cancer. Clin. Cancer Res., 2008, Vol. 14, no. 21, pp. 6735-6741.

24. Weinberg R.A. Mechanisms of malignant progression. Carcinogenesis, 2008, Vol. 29, pp. 1092-1095.

25. Wen Z., Ouyang Q., Chen D., Su X. Interleukin 18 expression in colon cancer and adenoma. Journal of Sichuan. Univ., 2003, Vol. 34, pp. 262-264.

26. Whitelock J., Iozzo R.V. Heparan sulfate: a complex polymer charged with biological activity. Chem. Rev., 2005, Vol. 105, pp. 2745-2764.

27. Xie Z., Liu Y., Jia L., He Y. Heparanase expression, degradation of basement membrane and low degree of infiltration by immunocytes correlate with invasion and progression of human gastric cancer. World J. Gastroenterol., 2008, Vol. 14, no. 24, pp. 3812-3818.

28. Yingying X., Yong Z., Zhenning W., Xue Z., Li J., Yang L., Huimian X. Role of heparanase-1 in gastric

29. carcinoma invasion. Asian Pacific. J. Cancer Prev., 2009, Vol. 10, no. 1, pp. 151-154.

30. Zheng L., Pu J., Jiang G., Weng M., He J., Mei H., Hou X., Tong Q. Abnormal expression of early growth response 1 in gastric cancer: association with tumor invasion, metastasis and heparanase transcription. Pathol. Int., 2010, Vol. 60, pp. 268-277.